As of my last update in October 2023, there is limited publicly available information on the chemical substance known as hMAO-B-IN-6 with the CAS number 2764830-43-3. Generally, compounds with such identifiers are often associated with specific biological activities, particularly in the context of medicinal chemistry or pharmacology. hMAO-B-IN-6 likely functions as an inhibitor of monoamine oxidase B (MAO-B), an enzyme involved in the metabolism of neurotransmitters such as dopamine. Inhibitors of MAO-B are of interest in the treatment of neurodegenerative diseases like Parkinson's disease, as they can help increase levels of dopamine in the brain. The characteristics of such compounds typically include their molecular structure, solubility, stability, and potential side effects, which are crucial for understanding their therapeutic efficacy and safety profile. For detailed information, including specific physical and chemical properties, further research in scientific literature or databases would be necessary.

hMAO-B-IN-6

2764830-43-3: As of my last update in October 2023, there is limited publicly available information on the chemical substance known as hMAO-B-IN-6 with the CAS number 2764830-43-3. Generally, compounds with such identifiers are often associated with specific biological activities, particularly in the context of medicinal chemistry or pharmacology. hMAO-B-IN-6 likely functions as an inhibitor of monoamine oxidase B (MAO-B), an enzyme involved in the metabolism of neurotransmitters such as dopamine. Inhibitors of MAO-B are of interest in the treatment of neurodegenerative diseases like Parkinson's disease, as they can help increase levels of dopamine in the brain. The characteristics of such compounds typically include their molecular structure, solubility, stability, and potential side effects, which are crucial for understanding their therapeutic efficacy and safety profile. For detailed information, including specific physical and chemical properties, further research in scientific literature or databases would be necessary.

<p>Compound 17d (hMAO-B-IN-6) is an effective and selective hMAO-B inhibitor, demonstrating an IC 50 of 67.02 nM. It significantly ameliorates cognitive deficits induced by Scopolamine in Alzheimer's disease (AD) mice [1].</p>

CAS 2764830-43-3

hMAO-B-IN-6

hMAO-B-IN-6

Ref: TM-T86585